LI ZHILIN (CEO and interim CFO) received a stock award from CHINA PHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/8/2021ACC: 0001213900-21-001170
DirectorOfficer10% Owner· CEO and interim CFO
Since Dec 2020
+2M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2M
Price / share
—
Trade value
—
% of position
19.9%
12/23/2020
10.05M→12.05M
Total
Net shares
+2M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/23/2020 | A · Award | +2M | — | — | 19.9% | 10.05M | 12.05M |
| Total | +2M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported